One of our long-term partners has just expanded their capacity for clinical and commercial HPAPI’s including cytotoxic linker-payloads for ADCs (up to OEL <10 ng/m3). For more information contact Austin Chemical.
One of our long-term partners has just expanded their capacity for clinical and commercial HPAPI’s including cytotoxic linker-payloads for ADCs (up to OEL <10 ng/m3). For more information contact Austin Chemical.